Achieving an Overwhelming No. 1 Position in Medical Equipment Distribution
First written in FY2016. 7 of 8 entries say "Restated". Latest entry: FY2024.
0 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「The Group aims for stable growth by strengthening proposals for its proprietary services, expanding its corporate scale through M&A, allocating resources efficiently and creating synergies, while also aiming to become a leading company in the industry in terms of performance.」
The Group continues to pursue industry leadership through proprietary services, M&A, resource allocation and synergies. - FY2022RestatedAnnual report
「The Group aims for stable growth by strengthening proposals for its proprietary services, expanding its corporate scale through M&A, allocating resources efficiently and creating synergies, while also aiming to become a leading company in the industry in terms of performance.」
The Group continues to pursue industry leadership through proprietary service proposals, M&A, resource allocation and synergies. - FY2021RestatedAnnual report
「The Group aims for stable growth by strengthening proposals for its proprietary services, expanding its corporate scale through M&A, allocating resources efficiently and creating synergies, while also aiming to become a leading company in the industry in terms of performance.」
The Group continues to pursue stable growth and industry leadership through proprietary service proposals, M&A, resource allocation and synergies. - FY2020RestatedAnnual report
「The Group aims for stable growth by strengthening proposals for its proprietary services, expanding its corporate scale through M&A, allocating resources efficiently and creating synergies, while also aiming to become a leading company in the industry in terms of performance.」
The Group reconfirms its policy of pursuing industry leadership through proprietary services, M&A, efficient resource allocation and synergies. - FY2019RestatedAnnual report
「We will continue to expand our scale and aim to become a leading company in the industry by strengthening consultative sales of high-value-added products through the provision of the latest medical information and by developing private-label products.」
The Group reiterates its aim of becoming a leading company in the industry through scale expansion, consultative sales and private-label products. - FY2018RestatedAnnual report
「We will continue to expand our scale and aim to become a leading company in the industry by strengthening consultative sales of high-value-added products through the provision of the latest medical information and by developing private-label products.」
Restates the aim of becoming an industry-leading company through scale expansion, consultative sales, and private-label products. - FY2017RestatedAnnual report
「The Group aims to become a leading company in the industry by strengthening consultative sales of high-value-added products supported by the provision of the latest medical information and expanding its private-label business.」
The Group reiterates its aim of becoming a leading company in the industry through consultative sales, private-label products and expansion of scale. - FY2016First statedAnnual report
「In addition, to achieve our management vision of becoming the overwhelming No. 1 company in the medical equipment distribution industry, we acquired and made 2 peer companies subsidiaries in July 2013 and July 2014. In October 2014, we also established a subsidiary to import and sell transfer equipment and electric beds for medical and nursing-care applications, thereby expanding the group’s market share.」
The vision of becoming the industry leader is presented together with acquisitions of peers and the establishment of a subsidiary as means of achieving it.